Earnings calendar

AngioDynamics, Inc. (ANGO) earnings: date, estimates, results and stock reactions

Next earnings: Q2 FY2027 on 2027-01-06 (expected, time not announced). EPS estimate -0.11, revenue estimate 84.2M.

Over the last 12 reports the stock moved 16.1% on average (either way), rising 6 times and falling 6. EPS beat estimates 10 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q1 FY20272026-10-08-0.04-0.11+64.4%80.9M80.5M-18.8%
Q4 FY20262026-07-14-0.07-0.11+36.4%86.6M80.2M+13.2%
Q3 FY20262026-04-02-0.07-0.11+36.4%78.4M76.8M-17.6%
Q2 FY20262026-01-06-0.15-0.10-50.0%79.4M76.4M-17.5%
Q1 FY20262025-10-02-0.10-0.14+28.6%75.7M76.3M+5.1%
Q4 FY20252025-07-15-0.03-0.13+76.9%80.2M74.3M-10.7%
Q3 FY20252025-04-020.03-0.13+123.1%72.0M74.3M+1.7%
Q2 FY20252025-01-08-0.04-0.11+63.6%72.8M70.6M+30.9%

ANGO stock report · Earnings calendar